Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients
Clinical trial NCT04150471 · UNKNOWN
Trial details
- NCT number
- NCT04150471
- Sponsor
- Seoul St. Mary's Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2018-10-18
- Primary completion
- 2020-12-30
- Enrollment
- 79
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.